Number of the records: 1
Alirocumab reduces total non-fatal and fatal cardiovascular events - from the ODYSSEY OUTCOMES study
- Alirocumab reduces total non-fatal and fatal cardiovascular events - from the ODYSSEY OUTCOMES study = Alirokumab redukuje všetky nefatálne kardiovaskulárne príhody i fatálne príhody - pokračovanie údajov ODYSSEY OUTCOMES štúdie / Murín J., Bulas J., Wawruch M.. Cardiology letters Vol. 28, no. 2-3 (2019), s. 94-98
article
Number of the records: 1